active ingredient semaglutide Last week's expiry of the patent for semaglutide—the in Novo Nordisk's blockbuster drugs that are used to treat both diabetes and obesity—unleashed a flurry of launches of low-cost generic versions People prescribed semaglutide – the

By Lauren Lund, APRN-CNP Reviewed by Laurianne Scott, DO Last Updated: 01/26/2025 In recent years, GLP-1 (glucagon-like peptide-1) medications have garnered significant attention for their effectiveness in helping individuals with weight loss

Since then, the company has established a strong regulatory and scientific foundation, with 12 USDMFs for peptides and 6 US ANDAs for peptide formulations, supported by a broader portfolio of 560+ USDMFs and 400+ bioequivalent formulations globally

Benjamin C.T

Good to know, clinical studies have also demonstrated that enzyme supplementation can improve recovery after exercise by regulating inflammation

Retatrutide can potentially help reduce workout fatigue and support endurance